Study Shows Connection Between Retinal Damage And Elmiron

Another study that links Elmiron to retinal damage has been published. New research published in Retina (The Journal of Retinal and Vitreous Diseases) indicates that exposure to pentosan polysulfate sodium (PPS) or Elmiron may increase the risk of vision problems and vision loss.

How Was the Retina Study Conducted?

Researchers sent questionnaires to individuals diagnosed with interstitial cystitis (IC).

IC is a bladder condition that can cause urinary frequency, urinary urgency, recurring pelvic pain, and pain or discomfort in the bladder. Elmiron is a commonly prescribed medication for the treatment of IC. Elmiron is the only oral medication currently approved by the Food and Drug Administration (FDA) for the treatment of IC.

The study discovered that respondents who took the highest doses of Elmiron were more likely to report vision issues, such as trouble reading small print. In addition, they reported a diagnosis of macular degeneration or pigmentary maculopathy. These rates were compared to respondents who did not use Elmiron.

Another Study That Supports Claims of Retinal Damage Linked to Elmiron

This latest study adds to the growing body of evidence linking PPS and Elmiron to retinal damage and vision loss. Other studies preceding the Retina study include the following:

Kaiser Permanente ophthalmologists discovered that chronic exposure to PPS was associated with the development of a distinct pigmentary maculopathy. PPS-related maculopathy continued to progress even after the patients stopped taking Elmiron.

From 2002 to 2016, researchers analysed data from a comprehensive U.S. medical claims database. Both PPS and control patients were studied. At the seven-year follow-up, PPS exposure was associated with significantly increased odds of a new diagnosis of macular disease.

At the 2019 AAO annual meeting, research linking Elmiron to retinal damage was presented. Patients with significant Elmiron exposure exhibited clear signs of eye damage. Vision loss or retinal damage may occur more frequently because the damage “masks” itself as pattern dystrophy or age-related macular degeneration.

According to a study of six adult patients, chronic exposure to PPS caused maculopathy. Patients experienced reading difficulties and prolonged dark adaptation. Elmiron’s long-term use may cause retinal damage.

Additional Research Continues to Point Toward a Link Between Elmiron and Retinal Damage

As more information becomes available, additional lawsuits against the makers of Elmiron, Janssen Pharmaceuticals, are likely. The long-term effects of PPS are still being investigated by researchers and physicians. Numerous lawsuits seeking damages for injuries caused by Elmiron have already been filed.

The Elmiron lawsuits allege that Janssen Pharmaceuticals failed to warn patients of the risk of vision loss and retinal damage. The company listed other side effects on the medication’s packaging, but it did not list maculopathy.

A drug manufacturer must inform consumers of the risks and side effects of medication. Failure to warn constitutes a product liability claim’s cause of action.

Plaintiffs assert that had they been aware of the possibility of permanent vision loss, they would not have chosen to take the drug. Because they were not made aware of the potential dangers, they suffered injuries and losses.

Damages Payable in an Elmiron Lawsuit

If a plaintiff is able to prove that the drug manufacturer is responsible for the injuries caused by Elmiron, the company may be required to compensate the victim for the following:

  • Costs associated with identifying eye damage and providing treatment and care
  • The permanent impairment and handicap resulting from vision loss and other injuries.
  • The price of individual care
  • Income, wages, and benefits lost
  • Permanent impairment-related reductions in earnings potential
  • Loss of life’s pleasure
  • Physical suffering and pain
  • mental agony and emotional suffering

The worth of your claim is determined by the specifics of your case. Your attorney will document your damages and work to recover the maximum compensation to which you are entitled.

What Should You Do if You Are Taking Elmiron and Are Diagnosed with Vision Loss or Retinal Damage?

If you are taking Elmiron, talk to your physician before stopping the medication. Your physician can review your options for treatment to help you decide what is best for your situation.

If you believe that Elmiron is responsible for your vision loss or retinal damage, you should immediately contact an Elmiron lawsuit attorney. The time limit for filing a claim against the drug manufacturer is short. Before filing a lawsuit, the attorney will need time to collect medical records and conduct research on your case.

Contact Our Personal Injury Law Firm

Contact Abrams Law Group for a free consultation if you’ve been hurt in an accident and require legal assistance.

Abrams Law Group
104-70 Queens Boulevard, Suite 502
Forest Hills, NY 11375
(718) 997-9797

Follow us on Instagram and Twitter for settlement updates

Leave a Comment

Your email address will not be published.

Scroll to Top